3 High-Yield Dividend Stocks to Load Up On Before 2026 Ends

The article highlights three consumer dividend stocks with valuation support: Realty Income just declared its 135th monthly dividend increase, yielding ~5.2% (vs ~1% for the S&P 500) on 99% occupancy and steady cash flow (~$4.27 FFO/share). Clorox is viewed as turning after prior disruptions, with investors paying ~22x earnings while its dividend is ~$5/share (yield ~4.7%) backed by ~$881M free cash flow vs ~$600M dividends. Campbell’s trades at ~11x P/E with a ~$1.56/share dividend (yield ~6.8%), with net earnings for the first nine months of fiscal 2026 of ~$1.55 supporting the payout; overall the message is a cautious-to-constructive income/valuation outlook into 2026.

Analysis

The common thread is not “cheapness” but duration: all three names are essentially different ways to own stable cash flows that the market has underwritten with too much pessimism. That makes them attractive only if rates stay contained or ease; if real yields back up, the dividend story gets mechanically less valuable and the multiple support disappears first in O, then in CLX/CPB. The immediate trade is less about earnings beats and more about who can sustain payout coverage without needing aggressive reinvestment.

For O, the second-order winner is tenant-quality exposure: Home Depot, FedEx, and Tractor Supply are implicitly being screened through a low-volatility landlord. If consumer spending softens, the market may initially treat O as defensive, but that works only if lease coverage and acquisition spreads hold; a slowdown in industrial/logistics activity would pressure renewal economics before it hits occupancy. For CLX and CPB, the key issue is whether the “recovery” comes from real volume or from price/mix and cost relief; the former supports a durable rerating, the latter does not.

The contrarian view is that these are classic value traps if investors confuse yield with safety. CPB’s premium-brand repositioning can be offset by private-label substitution, and CLX’s margin normalization may already be well-telegraphed. The setup is strongest over 1-3 months if rates fall or if upcoming prints show cleaner volume improvement; over 6-18 months, the winning stocks will be those with the best ability to grow FFO/earnings faster than the dividend, not simply maintain it.

Key Decisions for Investors

• Long O / short IYR or VNQ for 1-3 months: express the view that a high-quality net-lease name with explicit dividend credibility outperforms the broader REIT complex if rates drift lower; stop out if the 10-year Treasury re-approaches recent highs and cap-rate sensitivity reasserts.
• Watchlist, not a chase: buy CLX only on evidence of volume-led recovery in the next quarterly print; if growth is mostly price/mix, treat the move as a short-covering rally rather than a durable rerating. Falsifier: another quarter of flat-to-down organic volume.
• Pair CPB versus a private-label beneficiary basket over 3-6 months: the thesis works only if Campbell’s premiumization can defend share; if consumer trade-down accelerates, the cheaper-looking stock can still underperform. Falsifier: accelerating pantry-staples volume share gains for private label at major grocers.
• Avoid buying O solely for yield if the 10-year Treasury stays above the recent range; the stock’s multiple is more rate-sensitive than the headline dividend suggests. If rates break lower, re-rate the name quickly because the move can be fast and mechanical.
• If seeking a defensive basket, prefer O over CLX/CPB for near-term stability, but prefer CLX/CPB over O only if you have conviction that input-cost normalization will outpace private-label pressure over the next 2-4 quarters.